Mindray Medical International Limited
Mindray Medical International Limited, commonly known as Mindray, is a leading global provider of medical devices and solutions, headquartered in Shenzhen, China. Founded in 1991, the company has established a strong presence in over 190 countries, focusing on key operational regions such as North America, Europe, and Asia.
Specialising in the development of innovative medical technologies, Mindray's core business areas include patient monitoring and life support, in-vitro diagnostics, and medical imaging. The company is renowned for its high-quality products, such as advanced ultrasound systems and versatile anaesthesia machines, which are distinguished by their reliability and user-friendly design.
With a commitment to enhancing healthcare delivery, Mindray has achieved significant milestones, including numerous industry awards and recognitions. As a prominent player in the medical device industry, Mindray continues to drive advancements that improve patient outcomes and streamline clinical workflows.
-11 vs industry average
Mindray Medical International Limited’s score of 16 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Mindray Medical International Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Reported emissions
No reported emissions data is available for Mindray Medical International Limited yet.
Mindray Medical International Limited's reported carbon emissions
Mindray Medical International Limited, headquartered in China (CN), currently does not have available emissions data for the most recent year. However, the company has made notable strides in its climate commitments, particularly in reducing carbon emission intensity. In 2023, Mindray achieved an 8.51% decrease in carbon emission intensity compared to 2022, specifically targeting Scope 2 emissions.
While no specific total emissions figures are provided, the company's commitment to reducing its carbon footprint reflects a proactive approach to sustainability. Mindray's initiatives align with industry standards for climate action, demonstrating a focus on improving operational efficiency and reducing environmental impact.
As of now, there are no emissions data cascaded from a parent or related organization, indicating that Mindray is independently managing its climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Mindray Medical International Limited’s Climate Goals (2030 & 2050)
1 goal2023
8.51% reduction in Scope 2
In 2023, carbon emission intensity decreased by 8.51% compared to 2022.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project